Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability
Ferdy J. Lejeune
Ferdy J. Lejeune
Published August 15, 2002
Citation Information: J Clin Invest. 2002;110(4):433-435. https://doi.org/10.1172/JCI16493.
View: Text | PDF
Commentary Article has an altmetric score of 3

Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability

  • Text
  • PDF
Abstract

Commentary

Authors

Ferdy J. Lejeune

×

Total citations by year

Year: 2024 2020 2019 2017 2016 2014 2013 2012 2011 2010 2009 2008 2007 2006 Total
Citations: 1 2 1 1 2 2 1 1 1 1 1 2 2 1 19
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (19)

Title and authors Publication Year
Isolated Limb Perfusion for Extremity Soft Tissue Sarcoma and Malignant Melanoma
Russell M, Wilkinson M, Hayes A
Indian Journal of Surgical Oncology 2024
Targeted Antitumor Mechanism of C-PC/CMC-CD55sp Nanospheres in HeLa Cervical Cancer Cells.
Liu G, Xu X, Jiang L, Ji H, Zhu F, Jin B, Han J, Dong X, Yang F, Li B
Frontiers in pharmacology 2020
Interleukin-38 promotes tumor growth through regulation of CD8(+) tumor-infiltrating lymphocytes in lung cancer tumor microenvironment.
Kinoshita F, Tagawa T, Akamine T, Takada K, Yamada Y, Oku Y, Kosai K, Ono Y, Tanaka K, Wakasu S, Oba T, Osoegawa A, Shimokawa M, Oda Y, Hoshino T, Mori M
Cancer Immunology, Immunotherapy 2020
CEST MRI monitoring of tumor response to vascular disrupting therapy using high molecular weight dextrans.
Chen H, Liu D, Li Y, Xu X, Xu J, Yadav NN, Zhou S, van Zijl PCM, Liu G
Magnetic Resonance in Medicine 2019
A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment
A Cauwels, SV Lint, G Garcin, J Bultinck, F Paul, S Gerlo, JV der Heyden, Y Bordat, D Catteeuw, LD Cauwer, E Rogge, A Verhee, G Uzé, J Tavernier
OncoImmunology 2017
Alk5-Inhibition Increases Delivery of Macromolecular and Protein-Bound Contrast Agents to Tumors
Heike Daldrup-Link, suchismita mohanty, Celina Ansari, Olga Lenkov, Aubie Shaw, ken ito, Su Hyun Hong, Matthias Hofmann, Laura Pisani, Nancy Boudreau, Sanjiv Gambhir, Lisa Coussens
JCI Insight 2016
Sundew plant, a potential source of anti-inflammatory agents, selectively induces G2/M arrest and apoptosis in MCF-7 cells through upregulation of p53 and Bax/Bcl-2 ratio
NB Ghate, A Das, D Chaudhuri, S Panja, N Mandal
Cell Death Discovery 2016
Redox-Mediated and Ionizing-Radiation-Induced Inflammatory Mediators in Prostate Cancer Development and Treatment
L Miao, AK Holley, Y Zhao, WH st. Clair, DK st. Clair
Antioxidants & Redox Signaling 2014
TNF-α promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx: Risk of ALS after cancer
C Zhang, EM Sturgis, H Zheng, ME Zafereo, Q Wei, G Li
International Journal of Cancer 2014
Genetic variants in TNF -α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy: TNF -α variants and oropharyngeal cancer recurrence
C Zhang, EM Sturgis, H Zheng, X Song, P Wei, L Jin, L Chao, Q Wei, G Li
International Journal of Cancer 2013
Depletion of Regulatory T Lymphocytes Reverses the Imbalance between Pro- and Anti-Tumor Immunities via Enhancing Antigen-Specific T Cell Immune Responses
YL Chen, MC Chang, CA Chen, HW Lin, WF Cheng, CL Chien
PloS one 2012
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor
Y Li, J Wang, MG Wientjes, JL Au
Advanced Drug Delivery Reviews 2011
Squamous Carcinoma Cells Influence Monocyte Phenotype and Suppress Lipopolysaccharide-Induced TNF-alpha in Monocytes
A Lam-ubol, D Hopkin, EM Letuchy, ZB Kurago
Inflammation 2010
Vascular regeneration by local growth factor release is self-limited by microvascular clearance
KN Le, CW Hwang, AR Tzafriri, MA Lovich, A Hayward, ER Edelman
Circulation 2009
The role of tumor necrosis factor-alpha in systemic lupus erythematosus
M Aringer, JS Smolen
Arthritis Research & Therapy 2008
Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma.
Vairaktaris E, Yapijakis C, Serefoglou Z, Avgoustidis D, Critselis E, Spyridonidou S, Vylliotis A, Derka S, Vassiliou S, Nkenke E, Patsouris E
Journal of Cancer Research and Clinical Oncology 2008
Mast cells in vulnerable atherosclerotic plaques – a view to a kill
KA Lindstedt, MI Mäyränpää, PT Kovanen
Journal of Cellular and Molecular Medicine 2007
Tumor immunoediting and immunosculpting pathways to cancer progression
JM Reiman, M Kmieciak, MH Manjili, KL Knutson
Seminars in Cancer Biology 2007
Rat tumor response to the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid as measured by dynamic contrast-enhanced magnetic resonance imaging, plasma 5-hydroxyindoleacetic acid levels, and tumor necrosis.
McPhail LD, McIntyre DJ, Ludwig C, Kestell P, Griffiths JR, Kelland LR, Robinson SP
Neoplasia (New York, N.Y.) 2006

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
11 readers on Mendeley
See more details